UCSF - meropenem: indication-specific renal doses
- Product / population
- Adults; source-specific institutional guidance. Match route, indication and renal replacement modality.
- Renal measure
- CrCl in mL/min where specified; no equation inferred.
- Source revision
- Revision date not stated in the reviewed page.
- Retrieved
- 2026-09-05 (not the revision date)
Dosing / renal protocol and limits
IV short-infusion regimens for renal bands >50 / 26-50 / 10-25 / <10 mL/min:
- Standard: 1 g every 8 hours / 1 g every 12 hours / 500 mg every 12 hours / 500 mg daily.
- Meningitis or cystic fibrosis: 2 g every 8 hours / 2 g every 12 hours / 1 g every 12 hours / 1 g daily.
IHD: standard 500 mg initially, then every evening; meningitis/cystic fibrosis 1 g initially, then every evening.
CVVHD: standard 1 g every 8 hours; meningitis/cystic fibrosis 2 g every 12 hours. Discuss flow exceeding 2 L/hour with ID pharmacy.
Selected extended infusion uses a 1 g loading dose over 30 minutes, with maintenance beginning 4 hours later. At renal function >50 / 26-50, standard maintenance is 1 g over 3 hours every 8 / 12 hours; meningitis/cystic fibrosis maintenance is 2 g at those intervals. Below 26, use short infusion. Meningitis extended-infusion evidence is limited.
